ArticleOncotarget2019

DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model.

Takeshi Jimbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.